Jeffrey N. Martin

发表

A portable device for nucleic acid quantification powered by sunlight, a flame or electricity

R. Snodgrass, Andrea Gardner, A. Semeere, 2018, Nature Biomedical Engineering.

Variations in the heme oxygenase-1 microsatellite polymorphism are associated with plasma CD14 and viral load in HIV-infected African Americans

J. Witte, Jeffrey N. Martin, J. McCune, 2011, Genes and Immunity.

Decline in HIV infectivity following the introduction of highly active antiretroviral therapy

Jeffrey N. Martin, R. Grant, D. Osmond, 2003, AIDS.

Association of HIV-1 Gag-Specific IgG Antibodies With Natural Control of HIV-1 Infection in Individuals Not Carrying HLA-B*57: 01 Is Only Observed in Viremic Controllers.

Jeffrey N. Martin, S. Deeks, M. C. Tjiam, 2017, Journal of acquired immune deficiency syndromes.

Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell–Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification

Jeffrey N. Martin, S. Deeks, M. C. Tjiam, 2015, The Journal of Immunology.

Antibody Isotype Diversification against HIV-1 p24 Associated with Greater Opsonophagocytic IgG Antibody Responses Reactive - Plasmacytoid Dendritic Cell Viremic HIV Controllers Exhibit High

Jeffrey N. Martin, Sônia, S. Deeks, 2015 .

Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells.

Elizabeth Sinclair, Jeffrey N. Martin, D. Nixon, 2003, Journal of immunological methods.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

Jack T Stapleton, Stuart Haber, David Heckerman, 2010, Science.

Immune Activation, Cd4+ T Cell Counts, and Viremia Exhibit Oscillatory Patterns over Time in Patients with Highly Resistant HIV Infection

Jeffrey N. Martin, J. McCune, E. Sinclair, 2011, PloS one.

HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control

Steven G. Deeks, Elizabeth Sinclair, Jeffrey N. Martin, 2008, Journal of Virology.

Oral Candidiasis as a Marker of HIV Disease Progression Among Zimbabwean Women

Jeffrey N. Martin, C. Shiboski, J. Greenspan, 2008, Journal of acquired immune deficiency syndromes.

Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository

Reshma Kassanjee, Alex Welte, Shelley N. Facente, 2014, AIDS.

Internalized Stigma, Social Distance, and Disclosure of HIV Seropositivity in Rural Uganda

Alexander C. Tsai, Elias Kumbakumba, Conrad Muzoora, 2013, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

AIDS Alters the Commensal Plasma Virome

Eric Delwart, Steven G. Deeks, Mwebesa Bosco Bwana, 2013, Journal of Virology.

Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody Responses

Christos J. Petropoulos, Terri Wrin, Steven G. Deeks, 2006, Journal of Virology.

Rethinking the “Pre” in Pre-Therapy Counseling: No Benefit of Additional Visits Prior to Therapy on Adherence or Viremia in Ugandans Initiating ARVs

Nneka Emenyonu, Elvin Geng, Alexander C. Tsai, 2012, PloS one.

Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses

Jeffrey N. Martin, D. Waters, J. McCune, 2006, AIDS.

Clinical Resistance to Enfuvirtide Does Not Affect Susceptibility ofHuman Immunodeficiency Virus Type 1 to Other Classes of Entry Inhibitors

Steven G. Deeks, R. Doms, Jeffrey N. Martin, 2007, Journal of Virology.

Human Endogenous Retrovirus Expression Is Inversely Associated with Chronic Immune Activation in HIV-1 Infection

Steven G. Deeks, Mario A. Ostrowski, R. Brad Jones, 2012, PloS one.

Comparison of Self-Reported Alcohol Consumption to Phosphatidylethanol Measurement among HIV-Infected Patients Initiating Antiretroviral Treatment in Southwestern Uganda

David R. Bangsberg, Jessica E. Haberer, Peter Hunt, 2014, PloS one.

Impact of HIV on CD8+ T Cell CD57 Expression Is Distinct from That of CMV and Aging

Steven G. Deeks, Frederick M. Hecht, Elizabeth Sinclair, 2014, PloS one.

A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa.

C. Yiannoutsos, M. Petersen, Jeffrey N. Martin, 2012, American journal of epidemiology.

Super learner analysis of real‐time electronically monitored adherence to antiretroviral therapy under constrained optimization and comparison to non‐differentiated care approaches for persons living with HIV in rural Uganda

M. Petersen, Jeffrey N. Martin, D. Bangsberg, 2020, Journal of the International AIDS Society.

Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level Viremia

Jeffrey N. Martin, D. Kuritzkes, H. Hatano, 2012, Antimicrobial Agents and Chemotherapy.

A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIV.

Jeffrey N. Martin, M. Chesney, T. Coates, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.

Jeffrey N. Martin, J. Willig, F. Hecht, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunologic profiles distinguish aviremic HIV-infected adults

Jeffrey N. Martin, H. Hatano, F. Hecht, 2016, AIDS.

National estimates and predictors of prescription medication sample use in the United States, 1999-2005.

E. Vittinghoff, Jeffrey N. Martin, B. Guglielmo, 2010, Journal of the American Pharmacists Association : JAPhA.

Retention in Care and Connection to Care among HIV-Infected Patients on Antiretroviral Therapy in Africa: Estimation via a Sampling-Based Approach

C. Yiannoutsos, Jeffrey N. Martin, D. Glidden, 2011, PloS one.

A prospective ascertainment of cancer incidence in sub‐Saharan Africa: The case of Kaposi sarcoma

C. Yiannoutsos, A. Semeere, T. Maurer, 2016, Cancer medicine.

Diagnosing Kaposi’s Sarcoma (KS) in East Africa: how accurate are clinicians and pathologists?

Winnie Muyindike, Kara Wools-Kaloustian, Constantin Yiannoutsos, 2012, Infectious Agents and Cancer.

Real-world use of chemotherapy for Kaposi’s sarcoma in a large community-based HIV primary care system in Kenya

D. Seth, E. Freeman, A. Semeere, 2020, BMC Cancer.

Beyond T Staging in the Treat All Era: Capturing the Severity and Heterogeneity of Kaposi’s Sarcoma in East Africa

E. Freeman, A. Semeere, Jeffrey N. Martin, 2020 .

Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression

Jeffrey N. Martin, M. Siedner, K. Williams, 2018, Journal of acquired immune deficiency syndromes.

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia

Jeffrey N. Martin, R. Grant, S. Deeks, 2002, AIDS.

D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda

Jeffrey N. Martin, M. Siedner, K. Williams, 2016, Journal of acquired immune deficiency syndromes.

CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa.

Richard D Moore, E. Vittinghoff, C. Yiannoutsos, 2015, International journal of epidemiology.

Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension

Jeffrey N. Martin, S. Deeks, P. Hsue, 2008, AIDS.

Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, International Journal of Behavioral Medicine.

HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods

Jeffrey N. Martin, A. R. Mocello, D. Bangsberg, 2013, AIDS.

Ideal Cardiovascular Health and Carotid Atherosclerosis in a Mixed Cohort of HIV-Infected and Uninfected Ugandans.

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2016, AIDS research and human retroviruses.

HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy

Jeffrey N. Martin, M. Shlipak, S. Deeks, 2009, AIDS.

Association of Viral Persistence and Atherosclerosis in Adults With Treated HIV Infection

Jeffrey N. Martin, S. Deeks, R. Scherzer, 2020, JAMA network open.

Sampling-Based Approaches to Improve Estimation of Mortality among Patient Dropouts: Experience from a Large PEPFAR-Funded Program in Western Kenya

C. Yiannoutsos, Jeffrey N. Martin, C. Frangakis, 2008, PloS one.

Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNA

Jeffrey N. Martin, B. Peterlin, S. Deeks, 2018, PloS one.

Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers

Jeffrey N. Martin, M. Busch, S. Deeks, 2013, AIDS.

Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission.

Jeffrey N. Martin, P. Rosenthal, C. Brander, 2009, The Journal of infectious diseases.

HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality

M. Lederman, Jeffrey N. Martin, C. Meinert, 2014, PLoS pathogens.

SARS‐CoV‐2 and Mitochondrial Proteins in Neural‐Derived Exosomes of COVID‐19

M. Peluso, Jeffrey N. Martin, T. Henrich, 2022, Annals of neurology.

Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America

Sally S Bebawy, Richard D Moore, J. Goedert, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Substantial regional differences in human herpesvirus 8 seroprevalence in sub‐Saharan Africa: Insights on the origin of the “Kaposi's sarcoma belt”

Jeffrey N. Martin, C. Brander, C. Shiboski, 2010, International journal of cancer.

Moving toward clarity on 2 fronts in the epidemiology of Kaposi sarcoma-associated herpesvirus infection.

Jeffrey N. Martin, 2007, The Journal of infectious diseases.

Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic.

E. Vittinghoff, Jeffrey N. Martin, S. Buchbinder, 2002, JAMA.

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Sally S Bebawy, Richard D Moore, J. Margolick, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010.

Richard D Moore, J. Goedert, B. Lau, 2016, The Journal of infectious diseases.

Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.

Sally S Bebawy, Richard D Moore, J. Goedert, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Awareness of Kaposi's Sarcoma-Associated Herpesvirus Among Men Who Have Sex With Men

Jeffrey N. Martin, J. Catania, L. Pollack, 2008, Sexually transmitted diseases.

Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan Africa

Jeffrey N. Martin, D. Bangsberg, J. Hahn, 2009, Journal of acquired immune deficiency syndromes.

Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19

M. Peluso, Jeffrey N. Martin, T. Wrin, 2021, medRxiv.

The Factor Structure and Presentation of Depression Among HIV-Positive Adults in Uganda

Jeffrey N. Martin, D. Bangsberg, Y. Boum, 2014, AIDS and Behavior.

Drug-Bound CCR 5 and Extracellular Loop Domains of Antagonists Depends on both N-Terminal Cross-Resistance to Other CCR 5 A Maraviroc-Resistant HIV-1 with Narrow

F. Bushman, R. Doms, Jeffrey N. Martin, 2010 .

A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5

F. Bushman, R. Doms, Jeffrey N. Martin, 2010, Journal of Virology.

No Association Found Between Traditional Healer Use and Delayed Antiretroviral Initiation in Rural Uganda

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2011, AIDS and Behavior.

Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy.

Jeffrey N. Martin, M. Siedner, D. Kwon, 2016, The Journal of infectious diseases.

Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.

M. Lederman, Jeffrey N. Martin, C. Meinert, 2014, The Journal of infectious diseases.

Human Endogenous Retrovirus K106 (HERV-K106) Was Infectious after the Emergence of Anatomically Modern Humans

A. Jha, Jeffrey N. Martin, D. Nixon, 2011, PloS one.

Cross-Sectional Dating of Novel Haplotypes of HERV-K 113 and HERV-K 115 Indicate These Proviruses Originated in Africa before Homo sapiens

Emily C. Storm, A. Jha, Jeffrey N. Martin, 2009, Molecular biology and evolution.

Markers of Fungal Translocation Are Elevated During Post-Acute Sequelae of SARS-CoV-2 Infection and Induce NF-κB Triggered Inflammation

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2022, bioRxiv.

Diminishing Availability of Publicly Funded Slots for Antiretroviral Initiation among HIV-Infected ART-Eligible Patients in Uganda

Jeffrey N. Martin, D. Bangsberg, E. Geng, 2010, PloS one.

Failure to Initiate Antiretroviral Therapy, Loss to Follow-up and Mortality Among HIV-Infected Patients During the Pre-ART Period in Uganda

C. Yiannoutsos, Jeffrey N. Martin, D. Glidden, 2013, Journal of acquired immune deficiency syndromes.

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.

Richard D Moore, J. Goedert, Jeffrey N. Martin, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals.

Jeffrey N. Martin, P. Ganz, E. Secemsky, 2015, JACC. Heart failure.

Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 &Dgr;32

Emily B Hanhauser, F. Pereyra, Jeffrey N. Martin, 2015, AIDS.

Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor

T. Ndung’u, Jeffrey N. Martin, F. Hecht, 2015, Proceedings of the National Academy of Sciences.

Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

M. Peluso, Jeffrey N. Martin, D. Glidden, 2021, The Journal of infectious diseases.

Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection.

Jeffrey N. Martin, A. Sönnerborg, S. Deeks, 2013, Blood.

Levels of circulating myeloid subpopulations and of heme oxygenase-1 do not predict CD4+ T cell recovery after the initiation of antiretroviral therapy for HIV disease

Jeffrey N. Martin, G. M. Ortiz, J. McCune, 2014, AIDS Research and Therapy.

Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa.

Jeffrey N. Martin, D. Glidden, E. Geng, 2008, JAMA.

Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years.

Richard D Moore, Jennifer S. Lee, S. Cole, 2020, The Journal of infectious diseases.

Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals.

Jeffrey N. Martin, P. Ganz, C. Grunfeld, 2013, Atherosclerosis.

Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda

Jeffrey N. Martin, P. Harrigan, A. R. Mocello, 2016, AIDS.

HIV infection is associated with decreased thrombin generation.

Jeffrey N. Martin, C. Grunfeld, S. Deeks, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV

Jeffrey N. Martin, Min Li, S. Deeks, 2022, EBioMedicine.

Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection

Jeffrey N. Martin, P. Ganz, S. Deeks, 2014, AIDS.

Realtime adherence monitoring of antiretroviral therapy among hiv-infected adults and children in rural uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2013, AIDS.

Composition and Function of T Cell Subpopulations Are Slow to Change Despite Effective Antiretroviral Treatment of HIV Disease

Jeffrey N. Martin, D. Nixon, J. McCune, 2014, PloS one.

Brief Report: Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa?

Jeffrey N. Martin, P. Harrigan, M. Siedner, 2017, Journal of acquired immune deficiency syndromes.

Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection.

M. Lederman, Jeffrey N. Martin, C. Meinert, 2014, The Journal of infectious diseases.

Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus

Jeffrey N. Martin, F. Hecht, G. Beck-Engeser, 2020, The Journal of Infectious Diseases.

Some But Not All Biomarkers of Immune Activation Remain Abnormal Despite Very Early Treatment of HIV.

Jeffrey N. Martin, F. Hecht, G. Beck-Engeser, 2020, The Journal of infectious diseases.

Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells

J. Goedert, M. Carrington, B. Walker, 2018, Science.

Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers

Jeffrey N. Martin, H. Hatano, E. Sinclair, 2013, AIDS.

Epistatic Interactions between Fc (GM) and Fc γ R Genes and the Host Control of HIV Replication

Jeffrey N. Martin, S. Deeks, J. Pandey, 2012 .

Strong Human Endogenous Retrovirus-Speciﬁc T Cell Responses Are Associated with Control of HIV-1 in Chronic Infection (cid:1) †‡

Jeffrey N. Martin, D. Nixon, M. Ostrowski, 2011 .

Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2017, Journal of acquired immune deficiency syndromes.

Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.

Jeffrey N. Martin, E. Sinclair, L. Corey, 2011, The Journal of infectious diseases.

Infection With Different HIV Subtypes Is Associated With CD4 Activation-Associated Dysfunction and Apoptosis

Jeffrey N. Martin, D. Bangsberg, R. Harrigan, 2009, Journal of acquired immune deficiency syndromes.

Shifting Coronavirus Disease 2019 Testing Policy and Research to Include the Full Translation Pipeline

Jeffrey N. Martin, M. M. Dolcini, J. Catania, 2021, Open forum infectious diseases.

Cytotoxicity on HIV-1 Mediates Antibody-Dependent Cellular Ancestral Endogenous Virus Glycoproteins Cutting Edge: An Antibody Recognizing

Jeffrey N. Martin, D. Nixon, S. Deeks, 2014 .

Pulmonary arterial hypertension and HIV infection: authorsʼ reply

Jeffrey N. Martin, P. Hsue, 2008 .

Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring

Jeffrey N. Martin, D. Bangsberg, Y. Boum, 2017, AIDS.

Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2022, JCI insight.

Low Prevalence of Interferon-α Autoantibodies in People Experiencing Long COVID Symptoms

J. Derisi, M. Peluso, Jeffrey N. Martin, 2022, The Journal of infectious diseases.

Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2022, medRxiv : the preprint server for health sciences.

Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection

M. Peluso, Jeffrey N. Martin, D. Glidden, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection.

M. Peluso, A. Sette, Jeffrey N. Martin, 2022, AIDS.

Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, International Journal of Behavioral Medicine.

Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV‐Infected Adults

Jeffrey N. Martin, S. Deeks, R. Scherzer, 2019, Journal of the American Heart Association.

Rapid Emergence of Enfuvirtide Resistance in HIV-1-Infected Patients: Results of a Clonal Analysis

Rebecca Hoh, Daniel R Kuritzkes, Jeffrey N. Martin, 2006, Journal of acquired immune deficiency syndromes.

Clinical Resistance to Enfuvirtide Does Not Affect Susceptibility of Human Immunodeﬁciency Virus Type 1 to Other Classes of Entry Inhibitors (cid:1)

R. Doms, Jeffrey N. Martin, S. Deeks, 2007 .

Doppler echocardiography does not accurately estimate pulmonary artery systolic pressure in HIV-infected patients

Jeffrey N. Martin, S. Deeks, R. Scherzer, 2012, AIDS.

Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy

Jeffrey N. Martin, A. Carrico, T. Neilands, 2019, Journal of acquired immune deficiency syndromes.

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1

Amalio Telenti, Peter Parham, Stephen J O'Brien, 2007, Nature Genetics.

Higher CD27+CD8+ T Cells Percentages during Suppressive Antiretroviral Therapy Predict Greater Subsequent CD4+ T Cell Recovery in Treated HIV Infection

Jeffrey N. Martin, G. M. Ortiz, J. McCune, 2013, PloS one.

A public health approach to cervical cancer screening in Africa through community‐based self‐administered HPV testing and mobile treatment provision

Jeffrey N. Martin, A. Kambugu, M. Huchko, 2019, Cancer medicine.

Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda

Jeffrey N. Martin, M. Siedner, A. R. Mocello, 2015, Journal of acquired immune deficiency syndromes.

Universal Definition of Loss to Follow-Up in HIV Treatment Programs: A Statistical Analysis of 111 Facilities in Africa, Asia, and Latin America

B. Chi, C. Yiannoutsos, Jeffrey N. Martin, 2011, PLoS medicine.

Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects

Jeffrey N. Martin, L. Montaner, E. Papasavvas, 2012, Antiviral therapy.

The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.

Jeffrey N. Martin, J. McCune, D. Bangsberg, 2014, The Journal of infectious diseases.

Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2017, AIDS and Behavior.

Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy

M. Lederman, Jeffrey N. Martin, K. Williams, 2017, The Journal of infectious diseases.

Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection

M. Lederman, Jeffrey N. Martin, D. Moisi, 2021, Open forum infectious diseases.

CD56 neg CD16 + NK cells are activated mature NK cells with impaired effector function during HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2014 .

NK cells are activated mature NK cells with impaired effector function during HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2014 .

Immunoglobulin E (IgE) Levels are associated with Kaposi's Sarcoma in HIV-Infected African Adults.

Jeffrey N. Martin, H. Byakwaga, S. Mcallister, 2020, The Journal of infectious diseases.

UC Office of the President Recent Work Title The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD 4 + T cell recovery : a randomized crossover trial

Jeffrey N. Martin, J. Lifson, J. McCune, 2014 .

Comparison of an Interferon-γ Release Assay with Tuberculin Skin Testing in HIV-infected Individuals

Jeffrey N. Martin, D. Havlir, D. Bangsberg, 2007 .

Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals.

Jeffrey N. Martin, D. Havlir, D. Bangsberg, 2007, American journal of respiratory and critical care medicine.

Factors Associated With Access to and Timing of Coronavirus Testing Among US Adults After Onset of Febrile Illness

J. Olgin, M. Pletcher, E. Vittinghoff, 2021, JAMA network open.

Evaluation of SARS-CoV-2 nucleocapsid antigen in the blood as a diagnostic test for infection and infectious viral shedding

M. Peluso, Jeffrey N. Martin, D. Glidden, 2022, Open forum infectious diseases.

Abstract 2287: Diastolic Dysfunction is Common in Asymptomatic HIV Patients

Jeffrey N. Martin, A. Bolger, D. Waters, 2007 .

Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015.

Richard D Moore, Jennifer S. Lee, Jeffrey N. Martin, 2020, The Journal of infectious diseases.

T Cells Target APOBEC3 Proteins in Human Immunodeficiency Virus Type 1-Infected Humans and Simian Immunodeficiency Virus-Infected Indian Rhesus Macaques

Jeffrey N. Martin, D. Nixon, M. Ostrowski, 2013, Journal of Virology.

Self-Report of Alcohol Use Increases When Specimens for Alcohol Biomarkers Are Collected in Persons With HIV in Uganda.

Jeffrey N. Martin, D. Bangsberg, J. Hahn, 2012, Journal of acquired immune deficiency syndromes.

Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior

J. Kahn, R. Kohn, Jeffrey N. Martin, 2004, AIDS.

Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.

Jeffrey N. Martin, H. Hatano, F. Hecht, 2013, The Journal of infectious diseases.

HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells.

Jeffrey N. Martin, F. Hecht, J. McCune, 2011, Blood.

Lack of Evidence for mtDNA as a Biomarker of Innate Immune Activation in HIV Infection

Jeffrey N. Martin, M. Busch, S. Deeks, 2012, PloS one.

Human Herpesvirus Replication and Abnormal CD8+ T Cell Activation and Low CD4+ T Cell Counts in Antiretroviral-Suppressed HIV-Infected Patients

Jeffrey N. Martin, C. Shiboski, E. Sinclair, 2009, PloS one.

MR1-restricted MAIT-cell population in chronic HIV-1 infection Activation, exhaustion, and persistent decline of the antimicrobial

Jeffrey N. Martin, A. Sönnerborg, S. Deeks, 2013 .

Retention in Care and Patient-Reported Reasons for Undocumented Transfer or Stopping Care Among HIV-Infected Patients on Antiretroviral Therapy in Eastern Africa: Application of a Sampling-Based Approach.

C. Yiannoutsos, Jeffrey N. Martin, D. Glidden, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Contraceptive Use and Associated Factors among Women Enrolling into HIV Care in Southwestern Uganda

Jeffrey N. Martin, J. Hahn, N. Emenyonu, 2012, Infectious diseases in obstetrics and gynecology.

Gut epithelial barrier and systemic inflammation during chronic HIV infection

Jeffrey N. Martin, J. McCune, J. Inadomi, 2015, AIDS.

A common allele of HLA mediates asymptomatic SARS-CoV-2 infection

J. Olgin, M. Pletcher, G. Marcus, 2022, medRxiv.

INFLAMMATION IS ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION AMONG INDIVIDUALS WITH TREATED AND SUPPRESSED HIV INFECTION

Jeffrey N. Martin, P. Ganz, S. Deeks, 2010 .

Use of Saliva as a Lubricant in Anal Sexual Practices Among Homosexual Men

Jeffrey N. Martin, D. Osmond, L. Butler, 2009, Journal of acquired immune deficiency syndromes.

Variations in Plasmacytoid Dendritic Cell (PDC) and Myeloid Dendritic Cell (MDC) Levels in HIV-Infected Subjects on and off Antiretroviral Therapy

Jeffrey N. Martin, B. Schmidt, J. Levy, 2006, Journal of Clinical Immunology.

Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.

Marion C Lanteri, Jeffrey N. Martin, P. Borrow, 2014, AIDS research and human retroviruses.

Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, Cells.

The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA

Jeffrey N. Martin, P. Small, P. Hopewell, 1996, The Lancet.

Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms

M. Peluso, Jeffrey N. Martin, T. Wrin, 2021, Cell Reports.

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

M. Peluso, Jeffrey N. Martin, T. Wrin, 2021, Science Advances.

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

12, M. Peluso, Jeffrey N. Martin, 2021, medRxiv.

Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease

Jeff E. Mold, P. Loke, Jeffrey N. Martin, 2010, Science Translational Medicine.

Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings

A. Semeere, Jeffrey N. Martin, Jeffrey N Martin, 2012, Current opinion in oncology.

Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection

T. Maurer, Jeffrey N. Martin, R. Effros, 2013, AIDS.

Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

David R Bangsberg, Ronald J Bosch, M. Lederman, 2006, JAMA.

Factors Associated With Delayed Hepatitis B Viral Suppression on Tenofovir Among Patients Coinfected With HBV-HIV in the CNICS Cohort

Richard D Moore, Jeffrey N. Martin, S. Boswell, 2014, Journal of acquired immune deficiency syndromes.

High-Risk Sexual Behavior in Adults With Genotypically Proven Antiretroviral-Resistant HIV Infection

Jeffrey N. Martin, R. Grant, S. Deeks, 2005, Journal of acquired immune deficiency syndromes.

T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Jeffrey N. Martin, E. Sinclair, H. Lampiris, 2003, The Journal of infectious diseases.

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

M. Lederman, Jeffrey N. Martin, L. Picker, 2006, Nature Medicine.

Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV Disease

Jeffrey N. Martin, F. Hecht, J. McCune, 2010, PloS one.

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy

M. Lederman, Jeffrey N. Martin, S. Shade, 2003, AIDS.

Factors Associated with Delayed Hepatitis B Viral Suppression on Tenofovir Among HBV-HIV Coinfected Patients in the CNICS Cohort

Jeffrey N. Martin, S. Boswell, M. Mugavero, 2014 .

Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen.

Eoin Coakley, Rebecca Hoh, Peter Hunt, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy

Jeffrey N. Martin, C. Petropoulos, H. Hatano, 2010, Journal of acquired immune deficiency syndromes.

Partial treatment interruptions.

Jeffrey N. Martin, S. Deeks, Jeffrey N. Martin, 2007, Current opinion in HIV and AIDS.

Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2014, AIDS.

Regional anthropometry changes in antiretroviral-naïve persons initiating a Zidovudine-containing regimen in Mbarara, Uganda.

Jeffrey N. Martin, P. Tien, D. Bangsberg, 2011, AIDS research and human retroviruses.

Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy.

Jeffrey N. Martin, N. Jones, D. Bangsberg, 2007, AIDS research and human retroviruses.

The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda.

Jeffrey N. Martin, A. R. Mocello, D. Bangsberg, 2015, Contraception.

Incidence and Predictors of Pregnancy among a Cohort of HIV-Positive Women Initiating Antiretroviral Therapy in Mbarara, Uganda

Jeffrey N. Martin, R. Hogg, A. R. Mocello, 2013, PloS one.

Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.

M. Lederman, Jeffrey N. Martin, D. Douek, 2009, The Journal of infectious diseases.

Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals

Jeffrey N. Martin, H. Hatano, E. Delwart, 2010, AIDS.

Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus–Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter Study

Richard D Moore, Jeffrey N. Martin, M. Saag, 2019, Open forum infectious diseases.

Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy

Jeffrey N. Martin, D. Bangsberg, T. Neilands, 2011, AIDS.

Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection

M. Carrington, M. John, S. Mallal, 2017, AIDS.

HLA-C cell surface expression and control of HIV / AIDS correlate with a variant upstream of HLA-C

D. Ge, J. Goedert, M. Carrington, 2009 .

Seroconversion following nonoccupational postexposure prophylaxis against HIV.

J. Kahn, Jeffrey N. Martin, F. Hecht, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.

J. Kahn, Jeffrey N. Martin, M. Katz, 2004, Archives of internal medicine.

Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.

Jeffrey N. Martin, D. Douek, J. Brenchley, 2008, The Journal of infectious diseases.

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Peter Hunt, Lea Liu, J. Kahn, 2004, Blood.

Psoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease

G. McVean, M. Carrington, A. Bowcock, 2012, PLoS genetics.

Kaposi sarcoma

Jeffrey N. Martin, E. Cesarman, E. Farmer, 2019, Nature Reviews Disease Primers.

A portable device for nucleic acid quantification powered by sunlight, a flame or electricity

R. Snodgrass, Andrea Gardner, A. Semeere, 2018, Nature Biomedical Engineering.

The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa

Jeffrey N. Martin, D. Glidden, A. R. Mocello, 2015, Journal of acquired immune deficiency syndromes.

Diagnosis and epidemiology of human herpesvirus 8 infection.

Jeffrey N. Martin, Jeffrey N. Martin, 2003, Seminars in hematology.

Use of Epidemiologically Well-Defined Subjects and Existing Immunofluorescence Assays To Calibrate a New Enzyme Immunoassay for Human Herpesvirus 8 Antibodies

Jeffrey N. Martin, D. Osmond, D. Kedes, 2000, Journal of Clinical Microbiology.

Accuracy of Clinical Suspicion and Pathologic Diagnosis of Kaposi Sarcoma in East Africa

T. Maurer, Jeffrey N. Martin, K. Wools-Kaloustian, 2016, Journal of acquired immune deficiency syndromes.

Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi’s sarcoma in five countries across sub-Saharan Africa

E. Freeman, C. Yiannoutsos, K. Anastos, 2016, BMC Cancer.

Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy

Jeffrey N. Martin, H. Hatano, E. Delwart, 2008, Journal of Virology.

Plasma components affect accuracy of circulating cancer-related microRNA quantitation.

Joon Cheol Park, Jeffrey N. Martin, A. Gilman‐Sachs, 2012, The Journal of molecular diagnostics : JMD.

Relationship Power and Sexual Violence Among HIV-Positive Women in Rural Uganda

Amy A. Conroy, Jeffrey N. Martin, D. Bangsberg, 2016, AIDS and Behavior.

CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2014, AIDS.

Self-reported alcohol abstinence associated with ART initiation among HIV-infected persons in rural Uganda.

E. Vittinghoff, Jeffrey N. Martin, D. Bangsberg, 2014, Drug and alcohol dependence.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Michael J Silverberg, Bryan Lau, Michael S Saag, 2009, The New England journal of medicine.

Internalized stigma, depressive symptoms, and the modifying role of antiretroviral therapy: A cohort study in rural Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2021, SSM. Mental health.

Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion

Jeffrey N. Martin, M. Siedner, A. R. Mocello, 2015, AIDS.

In vitro functional assessment of natural HIV-1 group M Vpu sequences using a universal priming approach.

Jeffrey N. Martin, P. Harrigan, S. Ávila-Ríos, 2017, Journal of virological methods.

Mast Cell Activation and KSHV Infection in Kaposi Sarcoma

Jeffrey N. Martin, E. Cesarman, L. Ayers, 2018, Clinical Cancer Research.

Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection

Jeffrey N. Martin, M. Robb, G. Alter, 2017, Journal of Virology.

TCF-1 regulates HIV-specific CD8+ T cell expansion capacity

Jeffrey N. Martin, R. Koup, F. Hecht, 2020, JCI insight.

TCF-1 regulates the stem-like memory potential of HIV-specific CD8+ T cells in elite controllers

Jeffrey N. Martin, R. Koup, F. Hecht, 2020, bioRxiv.

Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.

Douglas S Kwon, Guoyan Zhao, Craig B Wilen, 2016, Cell host & microbe.

Impact of pre-existing chronic viral infection and reactivation on the development of long COVID.

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2022, The Journal of clinical investigation.

Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2

M. Peluso, Jeffrey N. Martin, J. Münch, 2024, Nature immunology.

Detection of Higher Cycle Threshold Values in Culturable SARS-CoV-2 Omicron BA.1 Sublineage Compared with Pre-Omicron Variant Specimens — San Francisco Bay Area, California, July 2021—March 2022

M. Peluso, R. Andino, Jeffrey N. Martin, 2022, MMWR. Morbidity and mortality weekly report.

Influence of HAART on Alternative Reading Frame Immune Responses over the Course of HIV-1 Infection

Jeffrey N. Martin, D. Nixon, W. Koff, 2012, PloS one.

Prevalence and correlates of physical and sexual intimate partner violence among women living with HIV in Uganda

Jeffrey N. Martin, D. Bangsberg, J. Haberer, 2018, PloS one.

Altered distribution of mucosal NK cells during HIV infection

Jeffrey N. Martin, G. Alter, D. Kwon, 2011, Mucosal Immunology.

Objective Identification of Cannabis Use Levels in Clinical Populations Is Critical for Detecting Pharmacological Outcomes.

Jeffrey N. Martin, N. Klatt, N. Isoherranen, 2021, Cannabis and cannabinoid research.

Prospective Study of the Mental Health Consequences of Sexual Violence Among Women Living With HIV in Rural Uganda

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2016, Journal of interpersonal violence.

High Levels of Antiretroviral Use and Viral Suppression Among Persons in HIV Care in the United States, 2010

Richard D Moore, M. Golden, Jeffrey N. Martin, 2013, Journal of acquired immune deficiency syndromes.

The Dynamic Relationship Between Social Support and HIV-Related Stigma in Rural Uganda

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2014, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

The social context of food insecurity among persons living with HIV/AIDS in rural Uganda.

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2011, Social science & medicine.

Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression

Jaclyn K. Mann, T. Ndung’u, Jeffrey N. Martin, 2017, Journal of Virology.

Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda

M. Carrington, Jeffrey N. Martin, P. Harrigan, 2021, AIDS.

HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses

Rachel E. Owen, Marion C Lanteri, Jeffrey N. Martin, 2010, AIDS.

Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals

Jaclyn K. Mann, T. Ndung’u, Jeffrey N. Martin, 2017, Journal of Virology.

HLA-B*14:02-Restricted Env-Specific CD8+ T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection

J. Goedert, M. Carrington, B. Walker, 2017, Journal of Virology.

HIV Controllers with HLA-DRB1*13 and HLA-DQB1*06 Alleles Have Strong, Polyfunctional Mucosal CD4+ T-Cell Responses

Jeffrey N. Martin, J. García, S. Deeks, 2010, Journal of Virology.

Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.

D. H. Young, Jeffrey N. Martin, J. García, 2009, Blood.

HLA-C downregulation by HIV-1 adapts to host HLA genotype

M. Carrington, Jeffrey N. Martin, R. Apps, 2018, PLoS pathogens.

Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment

Jeffrey N. Martin, D. Nixon, J. McCune, 2005, Journal of Virology.

Evolution of Phenotypic Drug Susceptibility and Viral Replication Capacity during Long-Term Virologic Failure of Protease Inhibitor Therapy in Human Immunodeficiency Virus-Infected Adults

M. Segal, Jeffrey N. Martin, T. Wrin, 2002, Journal of Virology.

Dual Pressure from Antiretroviral Therapy and Cell-Mediated Immune Response on the Human Immunodeficiency Virus Type 1 Protease Gene

Jeffrey N. Martin, G. M. Ortiz, D. Nixon, 2003, Journal of Virology.

Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms

Jeffrey N. Martin, S. Little, M. Busch, 2017, Journal of acquired immune deficiency syndromes.

Diagnostic, Infection Timing and Incidence Surveillance Applications of High Dynamic Range Chemiluminescent HIV Immuno-Assay Platforms

Jeffrey N. Martin, S. Little, M. Busch, 2017, bioRxiv.

Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting “Recent” HIV Infection and Calculating Population Incidence

Jeffrey N. Martin, S. Little, M. Busch, 2016, Journal of acquired immune deficiency syndromes.

Viral load criteria and threshold optimization to improve HIV incidence assay characteristics

Jeffrey N. Martin, S. Little, F. Hecht, 2016, AIDS.

HIV RNA testing in the context of nonoccupational postexposure prophylaxis.

J. Kahn, Jeffrey N. Martin, T. Elbeik, 2004, The Journal of infectious diseases.

In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Lamivudine

Jeffrey N. Martin, R. Paredes, D. Kuritzkes, 2008, Journal of Virology.

Continued evolution in gp41 after interruption of enfuvirtide in subjects with advanced HIV type 1 disease.

Marc A Suchard, Rebecca Hoh, Daniel R Kuritzkes, 2006, AIDS research and human retroviruses.

Immunodominant HIV-Specific CD8+ T-Cell Responses Are Common to Blood and Gastrointestinal Mucosa, and Gag-Specific Responses Dominate in Rectal Mucosa of HIV Controllers

Jeffrey N. Martin, J. García, S. Deeks, 2010, Journal of Virology.

Gag-Positive Reservoir Cells Are Susceptible to HIV-Specific Cytotoxic T Lymphocyte Mediated Clearance In Vitro and Can Be Detected In Vivo

Jeffrey N. Martin, S. Migueles, M. Connors, 2013, PloS one.

Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers

Jeffrey N. Martin, H. Hatano, J. McCune, 2013, PLoS pathogens.

A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers

Jeffrey N. Martin, H. Hatano, J. McCune, 2011, PloS one.

One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States

Sally S Bebawy, Richard D Moore, Jennifer S. Lee, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection

M. Carrington, B. Walker, M. John, 2017, Journal of Virology.

Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection

M. Carrington, B. Walker, M. John, 2017, Journal of Virology.

Implementation and Operational Research: Evaluating Outcomes of Patients Lost to Follow-up in a Large Comprehensive Care Treatment Program in Western Kenya

Elvin Geng, Paula Braitstein, Beth Rachlis, 2015, Journal of acquired immune deficiency syndromes.

Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009

C. Yiannoutsos, Jeffrey N. Martin, P. Easterbrook, 2011, Journal of the International AIDS Society.

Retention in Care among HIV-Infected Patients in Resource-Limited Settings: Emerging Insights and New Directions

C. Yiannoutsos, M. Petersen, Jeffrey N. Martin, 2010, Current HIV/AIDS reports.

Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach

Nneka Emenyonu, David V Glidden, Elvin H Geng, 2010, Journal of acquired immune deficiency syndromes.

Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa

C. Yiannoutsos, M. Petersen, Jeffrey N. Martin, 2014, AIDS.

Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection.

Rebecca Hoh, Torsten B Neilands, Robert M Grant, 2005, The Journal of infectious diseases.

Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study.

C. Yiannoutsos, Jeffrey N. Martin, D. Glidden, 2015, The lancet. HIV.

Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda.

Jeffrey N. Martin, P. Harrigan, D. Knapp, 2014, AIDS research and human retroviruses.

Delayed Switch of Antiretroviral Therapy Following Confirmed Virological Failure is Associated with Elevated Mortality among HIV-infected Adults in Africa.

C. Yiannoutsos, M. Petersen, Jeffrey N. Martin, 2014 .

Tracking a sample of patients lost to follow‐up has a major impact on understanding determinants of survival in HIV‐infected patients on antiretroviral therapy in Africa

Nneka Emenyonu, Winnie Muyindike, C. Yiannoutsos, 2010, Tropical medicine & international health : TM & IH.

The Causal Effect of Tracing by Peer Health Workers on Return to Clinic Among Patients Who Were Lost to Follow-up From Antiretroviral Therapy in Eastern Africa: A “Natural Experiment” Arising From Surveillance of Lost Patients

Kara Wools-Kaloustian, Wendy Hartogensis, Constantin Yiannoutsos, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008

Richard D Moore, Jeffrey N. Martin, R. Hogg, 2012, Annals of Internal Medicine.

Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population

Richard D Moore, M. Budoff, Jeffrey N. Martin, 2017, Journal of acquired immune deficiency syndromes.

Real-Time Adherence Monitoring for HIV Antiretroviral Therapy

Nneka Emenyonu, David R. Bangsberg, Jessica E. Haberer, 2010, AIDS and Behavior.

GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2013, AIDS.

HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers.

Jeffrey N. Martin, H. Hatano, J. McCune, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis

Jeffrey N. Martin, P. Ganz, S. Deeks, 2009, AIDS.

Late presentation for human immunodeficiency virus care in the United States and Canada.

Richard D Moore, J. Goedert, Jeffrey N. Martin, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.

Richard D Moore, J. Goedert, B. Lau, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Association Between Immunoglobulin E Levels and Kaposi Sarcoma in African Adults With Human Immunodeficiency Virus Infection

Jeffrey N. Martin, H. Byakwaga, C. King, 2020, The Journal of Infectious Diseases.

HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2016, Journal of acquired immune deficiency syndromes.

Relationship Between Kaposi Sarcoma–Associated Herpesvirus and HIV—Reply

Jeffrey N. Martin, D. Osmond, 2002 .

Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1.

Jeffrey N. Martin, T. Wrin, C. Petropoulos, 2004, The Journal of infectious diseases.

Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression.

F. Pereyra, B. Walker, R. Kaul, 2011, Blood.

Beyond T Staging in the “Treat-All” Era: Severity and Heterogeneity of Kaposi Sarcoma in East Africa

E. Freeman, A. Semeere, Jeffrey N. Martin, 2021, Journal of acquired immune deficiency syndromes.

Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection

Jeffrey N. Martin, A. Bolger, D. Waters, 2004, Circulation.

Measuring the overall genetic component of nevirapine pharmacokinetics and the role of selected polymorphisms: towards addressing the missing heritability in pharmacogenetic phenotypes?

Jeffrey N. Martin, L. Chinn, D. Kroetz, 2013, Pharmacogenetics and genomics.

Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia.

David W. Williamson, Jeffrey N. Martin, P. Harrigan, 2006, The Journal of infectious diseases.

Using Media to Promote Public Awareness of Early Detection of Kaposi's Sarcoma in Africa

T. Maurer, Jeffrey N. Martin, A. Kambugu, 2019, Journal of oncology.

Task Shifting and Skin Punch for the Histologic Diagnosis of Kaposi's Sarcoma in Sub-Saharan Africa: A Public Health Solution to a Public Health Problem

A. Semeere, T. Maurer, Jeffrey N. Martin, 2015, Oncology.

HIV-1 Genomes Are Enriched in Memory CD4+ T-Cells with Short Half-Lives

Jeffrey N. Martin, F. Hecht, J. McCune, 2021, mBio.

Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART

S. Mallal, Jeffrey N. Martin, J. Schiffer, 2021, PLoS pathogens.

Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2021, medRxiv.

Epistatic interactions between Fc (GM) and FcγR genes and the host control of human immunodeficiency virus replication.

Jeffrey N. Martin, S. Deeks, J. Pandey, 2012, Human immunology.

Effect of Long‐Term Highly Active Antiretroviral Therapy in Restoring HIV‐Induced Abnormal B‐Lymphocyte Function

Jeffrey N. Martin, M. Jacobson, V. Ng, 2002, Journal of acquired immune deficiency syndromes.

Transcriptional Errors in Human Immunodeficiency Virus Type 1 Generate Targets for T-Cell Responses

Jeffrey N. Martin, D. Nixon, F. Hecht, 2009, Clinical and Vaccine Immunology.

Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2014, Retrovirology.

Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers

Jeffrey N. Martin, M. Robb, G. Alter, 2017, Journal of Virology.

Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy.

R. Siliciano, M. Peluso, Jeffrey N. Martin, 2020, JCI insight.

Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.

Rebecca Hoh, Peter Bacchetti, Matthew C Strain, 2013, The Journal of infectious diseases.

A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response.

Jeffrey N. Martin, H. Hatano, J. McCune, 2011, The Journal of infectious diseases.

Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia

Z. Grossman, Jeffrey N. Martin, D. Nixon, 2004, AIDS.

Impact of HIV Infection on Diastolic Function and Left Ventricular Mass

Jeffrey N. Martin, A. Bolger, S. Deeks, 2010, Circulation. Heart failure.

Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans

J. Mefford, J. Witte, Jeffrey N. Martin, 2016, AIDS.

As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial

Jeffrey N. Martin, Minhee Kang, D. Dittmer, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Feasibility and implementation of portable confocal microscopy for point-of-care diagnosis of cutaneous lesions in a low-resource setting.

D. Seth, E. Freeman, M. Rajadhyaksha, 2020, Journal of the American Academy of Dermatology.

M. tuberculosis antigen-responsive IL17+ CD4 T cells are disproportionately spared in ART-suppressed HIV

Jeffrey N. Martin, J. Ernst, S. Deeks, 2023, bioRxiv.

HIV-Induced Changes in T Cell Signaling Pathways1

Jeffrey N. Martin, J. McCune, Marc Schweneker, 2008, The Journal of Immunology.

Reversal of the Kynurenine Pathway of Tryptophan Catabolism May Improve Depression in ART-Treated HIV-Infected Ugandans

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2014, Journal of acquired immune deficiency syndromes.

Strong Human Endogenous Retrovirus-Specific T Cell Responses Are Associated with Control of HIV-1 in Chronic Infection

Jeffrey N. Martin, D. Nixon, M. Ostrowski, 2011, Journal of Virology.

Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers

Jeffrey N. Martin, D. Nixon, F. Hecht, 2017, Retrovirology.

Geriatric Syndromes in Older HIV-Infected Adults

Jeffrey N. Martin, I. Cenzer, K. Covinsky, 2015, Journal of acquired immune deficiency syndromes.

Limited HIV Infection of Central Memory and Stem Cell Memory CD4+ T Cells Is Associated with Lack of Progression in Viremic Individuals

M. Lederman, Jeffrey N. Martin, F. Hecht, 2014, PLoS pathogens.

CD 56 negCD 16 + NK cells are activated mature NK cells with impaired effector function during HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2014 .

CD56negCD16+ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2013, Retrovirology.

Point-of-Care C-Reactive Protein Testing to Facilitate Implementation of Isoniazid Preventive Therapy for People Living With HIV

Jeffrey N. Martin, D. Bangsberg, P. Nahid, 2014, Journal of acquired immune deficiency syndromes.

Depression During Pregnancy and the Postpartum Among HIV-Infected Women on Antiretroviral Therapy in Uganda

Jeffrey N. Martin, D. Bangsberg, Y. Boum, 2014, Journal of acquired immune deficiency syndromes.

Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.

Jeffrey N. Martin, D. Nixon, F. Hecht, 2012, Blood.

Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States

J. Kahn, Jeffrey N. Martin, M. Katz, 2004, AIDS.

Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies

M. Peluso, Jeffrey N. Martin, T. Henrich, 2022, Pathogens & immunity.

Changes in Food Insecurity, Nutritional Status, and Physical Health Status After Antiretroviral Therapy Initiation in Rural Uganda

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2012, Journal of acquired immune deficiency syndromes.

Food insecurity, depression and the modifying role of social support among people living with HIV/AIDS in rural Uganda.

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2012, Social science & medicine.

Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care

Richard D Moore, B. Lau, Jeffrey N. Martin, 2012, AIDS.

Ten-year Survival by Race/Ethnicity and Sex Among Treated, HIV-infected Adults in the United States.

Jessie K. Edwards, Richard D Moore, S. Cole, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Retention Among North American HIV-Infected Persons in Clinical Care, 2000–2008

Richard D Moore, Jeffrey N. Martin, R. Hogg, 2013, Journal of acquired immune deficiency syndromes.

Presenting Plasma HIV RNA Level and Rate of CD4 T-Cell Decline—Reply

M. Lederman, Jeffrey N. Martin, R. Bosch, 2007 .

Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor setting

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2012, AIDS.

Sexual Relationship Power and Malnutrition Among HIV-Positive Women in Rural Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2012, AIDS and Behavior.

Antiretroviral Therapy Adherence Interruptions Are Associated With Systemic Inflammation Among Ugandans Who Achieved Viral Suppression.

Jeffrey N. Martin, M. Siedner, T. Burdo, 2019, Journal of acquired immune deficiency syndromes.

High incidence of intended partner pregnancy among men living with HIV in rural Uganda: Implications for safer conception services.

Jeffrey N. Martin, D. Bangsberg, Y. Boum, 2019, Journal of acquired immune deficiency syndromes.

Disinhibition in Risky Sexual Behavior in Men, but Not Women, during Four Years of Antiretroviral Therapy in Rural, Southwestern Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2013, PloS one.

CD4+ T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa

Richard D Moore, E. Vittinghoff, C. Yiannoutsos, 2015 .

The independent effect of drug resistance on T cell activation in HIV infection

Jeffrey N. Martin, E. Sinclair, D. Bangsberg, 2006, AIDS.

CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?

Richard D Moore, J. Goedert, Jeffrey N. Martin, 2010, AIDS research and therapy.

Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19

M. Peluso, Jeffrey N. Martin, T. Henrich, 2022, Annals of clinical and translational neurology.

Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, Journal of neurovirology.

HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda

Jeffrey N. Martin, M. Siedner, D. Kwon, 2016, AIDS.

"Food Insecurity is Associated with Morbidity and Patterns of Healthcare Utilization among HIV-Infected Individuals in Rural Uganda."

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2012 .

The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease

Jeffrey N. Martin, F. Hecht, P. Ganz, 2012, AIDS.

Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients

Jeffrey N. Martin, H. Hatano, P. Ganz, 2009, AIDS.

A Randomized Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection

Jeffrey N. Martin, H. Hatano, E. Sinclair, 2012, Journal of acquired immune deficiency syndromes.

Tobacco Use Among Adults Initiating Treatment for HIV Infection in Rural Uganda

N. Rigotti, Jeffrey N. Martin, D. Bangsberg, 2014, AIDS and Behavior.

HIV and Premature Aging: A Field Still in Its Infancy

P. Volberding, Jeffrey N. Martin, 2010, Annals of Internal Medicine.

Inflammation during early post-acute COVID-19 is associated with reduced exercise capacity and Long COVID symptoms after 1 year.

C. Long, M. Peluso, Jeffrey N. Martin, 2022, medRxiv : the preprint server for health sciences.

IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells

Jeffrey N. Martin, P. Haaland, D. Nixon, 2006, AIDS research and therapy.

History-adjusted marginal structural models for estimating time-varying effect modification.

Mark J van der Laan, Maya L Petersen, M. J. van der Laan, 2007, American journal of epidemiology.

Cooking fuel and respiratory symptoms among people living with HIV in rural Uganda

Jeffrey N. Martin, D. Christiani, M. Siedner, 2017, ERJ Open Research.

Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers.

P. Loke, Jeffrey N. Martin, J. McCune, 2010, Blood.

Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection

M. Peluso, A. Sette, Jeffrey N. Martin, 2022 .

Magnitude and determinants of SARS-CoV-2 household transmission: a longitudinal cohort study

M. Peluso, R. Andino, Jeffrey N. Martin, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection

Jeffrey N. Martin, P. Ganz, S. Deeks, 2016, PloS one.

Cross-Sectional Dating of Novel of and Indicate These Proviruses Originated in Africa before Homo sapiens

Emily C. Storm, A. Jha, Jeffrey N. Martin, 2009 .

Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease

Jeffrey N. Martin, D. Glidden, H. Hatano, 2014, AIDS.

Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2022, JCI insight.

Contraceptive use following unintended pregnancy among Ugandan women living with HIV

Jeffrey N. Martin, D. Bangsberg, Y. Boum, 2018, PloS one.

Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression

R. Greenblatt, K. Anastos, M. Young, 2017, Journal of Virology.

How Does Antiretroviral Treatment Attenuate the Stigma of HIV? Evidence from a Cohort Study in Rural Uganda

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2013, AIDS and Behavior.

Sexual Relationship Power and Depression among HIV-Infected Women in Rural Uganda

Jeffrey N. Martin, D. Bangsberg, A. Tsai, 2012, PloS one.

Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals

Jeffrey N. Martin, F. Hecht, P. Ganz, 2010, AIDS.

Estimation of Mortality among HIV-infected people on antiretroviral therapy treatment in east Africa: a sampling based approach in an observational, multisite, cohort study.

C. Yiannoutsos, Jeffrey N. Martin, D. Glidden, 2015, The lancet. HIV.

Mitral Annular and Coronary Artery Calcification Are Associated with Mortality in HIV-Infected Individuals

Jeffrey N. Martin, D. Glidden, A. Bolger, 2015, PloS one.

The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial.

M. Lederman, Jeffrey N. Martin, T. Schacker, 2013, Blood.

Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV Infection.

Jeffrey N. Martin, J. McCune, S. Deeks, 2019, Journal of acquired immune deficiency syndromes.

The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection.

Jeffrey N. Martin, M. Schambelan, S. Deeks, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, medRxiv.

Evidence for the Reliability and Validity of the Internalized AIDS-Related Stigma Scale in Rural Uganda

Wayne T. Steward, Jeffrey N. Martin, W. Steward, 2012, AIDS and Behavior.

Elevated Plasma von Willebrand Factor Levels Are Associated With Subsequent Ischemic Stroke in Persons With Treated HIV Infection

Jeffrey N. Martin, M. Wurfel, C. Marra, 2021, Open forum infectious diseases.

Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States

Sally S Bebawy, Richard D Moore, K. Anastos, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Central Memory CD4+ T Cell Responses in Chronic HIV Infection Are Not Restored by Antiretroviral Therapy1

Jeffrey N. Martin, S. Deeks, R. Hoh, 2004, The Journal of Immunology.

MultiSero: An Open-Source Multiplex-ELISA Platform for Measuring Antibody Responses to Infection

Shalin B. Mehta, Bryant B. Chhun, M. Peluso, 2023, Pathogens.

Prolonged and Substantial Discordance in Prevalence of Raltegravir-Resistant HIV-1 in Plasma versus PBMC Samples Revealed by 454 “Deep” Sequencing

Jeffrey N. Martin, P. Harrigan, M. Wainberg, 2012, PLoS ONE.

Differential Expression of CD96 Surface Molecule Represents CD8+ T Cells with Dissimilar Effector Function during HIV-1 Infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2012, PloS one.

Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches

Jeffrey N. Martin, P. Harrigan, M. Siedner, 2017, AIDS.

E-values and incidence density sampling.

Maya B. Mathur, T. VanderWeele, Jeffrey N. Martin, 2020, Epidemiology.

MicroRNA biomarkers associated with type 1 myocardial infarction in HIV positive individuals.

Jeffrey N. Martin, K. Tanriverdi, R. Scherzer, 2019, AIDS.

Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation

Jeffrey N. Martin, A. Bolger, P. Ganz, 2012, Journal of the American Heart Association.

Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calcium.

Jeffrey N. Martin, D. Waters, P. Ganz, 2012, The American journal of cardiology.

Tutorial on Directed Acyclic Graphs.

Jeffrey N. Martin, M. Glymour, J. Digitale, 2021, Journal of clinical epidemiology.

The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms

M. Peluso, Jeffrey N. Martin, T. Wrin, 2023, medRxiv.

Chronic viral coinfections differentially affect the likelihood of developing long COVID

M. Peluso, Jeffrey N. Martin, C. Petropoulos, 2023, The Journal of Clinical Investigation.

Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, Open forum infectious diseases.

A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis

Jeffrey N. Martin, B. Autran, J. McCune, 2012, AIDS.

T cell immunosenescence is associated with the presence of Kaposi’s sarcoma in antiretroviral treated human immunodeficiency virus-infected persons

T. Maurer, Jeffrey N. Martin, E. Sinclair, 2010, Infectious Agents and Cancer.

Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2018, Annals of Internal Medicine.

Longitudinal and Quantitative Fecal Shedding Dynamics of SARS-CoV-2, Pepper Mild Mottle Virus and CrAssphage

M. Peluso, R. Andino, Jeffrey N. Martin, 2023, medRxiv.

Empiric Deworming and CD4 Count Recovery in HIV-Infected Ugandans Initiating Antiretroviral Therapy

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2014, PLoS neglected tropical diseases.

Discordance Between Peripheral and Colonic Markers of Inflammation During Suppressive ART

M. J. Broadhurst, M. Lederman, P. Loke, 2014, Journal of acquired immune deficiency syndromes.

Association between Guillain-Barré syndrome and Zika virus infection

Jeffrey N. Martin, V. Avelino-silva, 2016, The Lancet.

Declining Prevalence of Probable Depression Among Patients Presenting for Antiretroviral Therapy in Rural Uganda: The Role of Early Treatment Initiation

Jeffrey N. Martin, A. R. Mocello, D. Bangsberg, 2014, AIDS and Behavior.

Indoleamine 2,3 dioxygenase, age, and immune activation in people living with HIV

Jeffrey N. Martin, M. Saag, A. Mellor, 2021, Journal of Investigative Medicine.

Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients

Mark S. Anderson, J. Derisi, M. Peluso, 2023, JCI insight.

Prevalence, correlates, and predictive value of high-risk human papillomavirus mRNA detection in a community-based cervical cancer screening program in western Uganda

Jeffrey N. Martin, M. Huchko, F. Mubiru, 2019, Infectious Agents and Cancer.

A closer look at hepatitis C clearance in HIV controllers: a response.

Jeffrey N. Martin, M. Busch, S. Deeks, 2014, AIDS.

Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study

M. Peluso, Jeffrey N. Martin, T. Henrich, 2021, medRxiv.

Trends in one-year cumulative incidence of death between 2005 and 2013 among patients initiating antiretroviral therapy in Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2017, International journal of STD & AIDS.

Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2014, AIDS.

Early Biological Markers of Post-Acute Sequelae of SARS-CoV-2 Infection

Winslow, M. Peluso, Jeffrey N. Martin, 2023, medRxiv.

Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design

Michael I. Jordan, David E. Warren, David W. Chestek, 2023, medRxiv.

The cure of the 'Berlin patient': why did pre-existing X4-variants not emergence after allogeneic CCR5-Delta 32 SCT?

Jeffrey N. Martin, S. Deeks, L. Vandekerckhove, 2012 .

Reply to Shulman et al.

Jeffrey N. Martin, S. Deeks, P. Hunt, 2007 .

SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency.

M. Peluso, Jeffrey N. Martin, T. Henrich, 2023, American journal of epidemiology.

Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa

E. Freeman, C. Yiannoutsos, C. Adebamowo, 2017, BMC Cancer.

HIV antibody characterization as a method to quantify reservoir size during curative interventions.

Jeffrey N. Martin, J. Kovacs, S. Deeks, 2014, The Journal of infectious diseases.

Practice of Epidemiology Estimation of the Standardized Risk Difference and Ratio in a Competing Risks Framework : Application to Injection Drug Use and Progression to AIDS After Initiation of Antiretroviral Therapy

S. Cole, B. Lau, Jeffrey N. Martin, 2015 .

Plasma Interleukin-6 (IL-6), Angiopoietin-2, and C-Reactive Protein Levels Predict Subsequent Type 1 Myocardial Infarction in Persons With Treated HIV Infection

M. Budoff, Jeffrey N. Martin, M. Wurfel, 2023, Journal of acquired immune deficiency syndromes.

Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening.

Richard D Moore, J. Goedert, B. Lau, 2011, The Journal of infectious diseases.

Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda

Jeffrey N. Martin, M. Siedner, D. Bangsberg, 2018, Journal of acquired immune deficiency syndromes.

The Activity of the Integrase Inhibitor Dolutegravir Against HIV-1 Variants Isolated From Raltegravir-Treated Adults

Jeffrey N. Martin, S. Deeks, T. Fujiwara, 2012, Journal of acquired immune deficiency syndromes.

A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection

J. Olgin, M. Pletcher, G. Marcus, 2023, Nature.

Implementation and Operational Research: Use of Symptom Screening and Sputum Microscopy Testing for Active Tuberculosis Case Detection Among HIV-Infected Patients in Real-World Clinical Practice in Uganda

Jeffrey N. Martin, E. Geng, Monika Roy, 2016, Journal of acquired immune deficiency syndromes.

Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons.

Jeffrey N. Martin, S. Deeks, K. Mulligan, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers

Jeffrey N. Martin, D. Nixon, F. Hecht, 2017, Retrovirology.

Kaposi sarcoma.

Jeffrey N. Martin, E. Cesarman, B. Damania, 2020, Nature Reviews Disease Primers.

Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada

James J. Goedert, Sharada P. Modur, Mari M. Kitahata, 2013, PloS one.

Longitudinal and quantitative fecal shedding dynamics of SARS-CoV-2, pepper mild mottle virus, and crAssphage

M. Peluso, R. Andino, Jeffrey N. Martin, 2023, mSphere.

Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2

M. Peluso, Jeffrey N. Martin, J. Münch, 2023, bioRxiv.

Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19

M. Peluso, Jeffrey N. Martin, Youngho Seo, 2023, medRxiv.

Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients

Mark S. Anderson, J. Derisi, M. Peluso, 2023, medRxiv.

Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.

J. Gerberding, Jeffrey N. Martin, F. Perdreau-Remington, 1999, The Journal of infectious diseases.

Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen.

Wei Huang, Rebecca Hoh, Torsten B Neilands, 2007, The Journal of infectious diseases.

Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B‐coinfected adults in care in the United States

Jeffrey N. Martin, K. Reddy, M. Kallan, 2023, Journal of viral hepatitis.

Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study.

Richard D Moore, Jennifer S. Lee, J. Margolick, 2019, The lancet. HIV.

Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.

J. Kahn, Jeffrey N. Martin, M. Chesney, 2001, The Journal of infectious diseases.

ASYMMETRIC DIMETHYLARGININE LEVELS ARE ASSOCIATED WITH PULMONARY ARTERIAL HYPERTENSION IN HIV-INFECTED INDIVIDUALS

Jeffrey N. Martin, P. Ganz, S. Deeks, 2012 .

Cutting Edge: An Antibody Recognizing Ancestral Endogenous Virus Glycoproteins Mediates Antibody-Dependent Cellular Cytotoxicity on HIV-1–Infected Cells

Jeffrey N. Martin, D. Nixon, S. Deeks, 2014, The Journal of Immunology.

CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018

Richard D Moore, Jennifer S. Lee, Jeffrey N. Martin, 2020, Clinical Infectious Diseases.

Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity

M. Carrington, Jeffrey N. Martin, P. Harrigan, 2018, Journal of Virology.

Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen.

Jeffrey N. Martin, N. Parkin, S. Deeks, 2004, AIDS.

Sexual transmission and the natural history of human herpesvirus 8 infection.

Jeffrey N. Martin, D. Osmond, D. Ganem, 1998, The New England journal of medicine.

HLA-C downregulation by HIV-1 adapts to host HLA genotype

M. Carrington, Jeffrey N. Martin, R. Apps, 2018, PLoS pathogens.

Optimizing Network Connectivity for Mobile Health Technologies in sub-Saharan Africa

Mark J. Siedner, Alexander Lankowski, Derrick Musinga, 2012, PloS one.

Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure.

J. Kahn, Jeffrey N. Martin, R. Grant, 2001, The Journal of infectious diseases.

Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes

Rosemary M. McCloskey, Jaclyn K. Mann, B. Walker, 2013, Retrovirology.

Increasing Prevalence of HIV Pretreatment Drug Resistance in Women But Not Men in Rural Uganda During 2005‐2013

Jeffrey N. Martin, P. Harrigan, M. Siedner, 2018, AIDS patient care and STDs.

Association between U.S. State AIDS Drug Assistance Program (ADAP) Features and HIV Antiretroviral Therapy Initiation, 2001–2009

Richard D Moore, E. Stuart, Jeffrey N. Martin, 2013, PloS one.

Multi-Center Phase II Study of Perifosine (KRX-0401) Alone and in Combination with Dexamethasone (dex) for Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Promising Activity as Combination Therapy with Manageable Toxicity.

A. Jakubowiak, S. Lonial, Jeffrey N. Martin, 2007 .

Gut epithelial barrier and systemic inflammation during chronic HIV infection

Jeffrey N. Martin, J. McCune, J. Inadomi, 2015, AIDS.

HIV Drug Resistance Testing by High-Multiplex “Wide” Sequencing on the MiSeq Instrument

Jeffrey N. Martin, P. Harrigan, A. R. Mocello, 2015, Antimicrobial Agents and Chemotherapy.

Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy

Jeffrey N. Martin, H. Hatano, E. Delwart, 2008, Journal of Virology.

Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.

Jeffrey N. Martin, S. Deeks, R. Pollard, 2009, Blood.

HIV Controllers with HLA-DRB1*13 and HLA-DQB1*06 Alleles Have Strong, Polyfunctional Mucosal CD4+ T-Cell Responses

Jeffrey N. Martin, J. García, S. Deeks, 2010, Journal of Virology.

HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells.

Jeffrey N. Martin, F. Hecht, J. McCune, 2011, Blood.

Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients

Jeffrey N. Martin, H. Hatano, P. Ganz, 2009, AIDS.

Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis

Jeffrey N. Martin, P. Ganz, S. Deeks, 2009, AIDS.

AIDS Alters the Commensal Plasma Virome

Jeffrey N. Martin, E. Delwart, D. Bangsberg, 2013, Journal of Virology.

Biomarker Testing to Estimate Under-Reported Heavy Alcohol Consumption by Persons with HIV Initiating ART in Uganda

Jeffrey N. Martin, D. Bangsberg, M. Javors, 2010, AIDS and Behavior.